CD44 and breast carcinoma: We observed the selective packaging of P-gp, CD44, Ezrin, Radixin, and Moesin in MDR breast cancer derived MPs together with 117 other proteins unique to the resistance cargo, which we proposed may play a role in establishing the MDR phenotype in cancer cell populations [62].